148 related articles for article (PubMed ID: 18250117)
1. Successful management of difficult infusion-associated reactions in a young patient with mucopolysaccharidosis type VI receiving recombinant human arylsulfatase B (galsulfase [Naglazyme]).
Kim KH; Decker C; Burton BK
Pediatrics; 2008 Mar; 121(3):e714-7. PubMed ID: 18250117
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytopenia associated with galsulfase treatment.
Doğan M; Cesur Y; Peker E; Oner AF; Dogan SZ
Hum Exp Toxicol; 2011 Jul; 30(7):768-71. PubMed ID: 20670992
[TBL] [Abstract][Full Text] [Related]
3. Galsulfase: arylsulfatase B, BM 102, recombinant human arylsulfatase B, recombinant human N-acetylgalactosamine-4-sulfatase, rhASB.
Drugs R D; 2005; 6(5):312-5. PubMed ID: 16128602
[TBL] [Abstract][Full Text] [Related]
4. Enzyme replacement therapy with galsulfase for mucopolysaccharidosis VI: clinical facts and figures.
Harmatz P
Turk J Pediatr; 2010; 52(5):443-9. PubMed ID: 21434527
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics, pharmacokinetics and biodistribution of recombinant human N-acetylgalactosamine 4-sulfatase after 6months of therapy in cats using different IV infusion durations.
Ruane T; Haskins M; Cheng A; Wang P; Aguirre G; Knox VW; Qi Y; Tompkins T; O'Neill CA
Mol Genet Metab; 2016 Feb; 117(2):157-63. PubMed ID: 26776148
[TBL] [Abstract][Full Text] [Related]
6. Enzyme replacement therapy in the home setting for mucopolysaccharidosis VI: a survey of patient characteristics and physicians' early findings in the United States.
Tifft C; Proud V; Levy P; DeMarco K; Nicely H; Turbeville S
J Infus Nurs; 2009; 32(1):45-52. PubMed ID: 19142150
[TBL] [Abstract][Full Text] [Related]
7. Enzyme replacement therapy with galsulfase in 34 children younger than five years of age with MPS VI.
Horovitz DD; Magalhães TS; Acosta A; Ribeiro EM; Giuliani LR; Palhares DB; Kim CA; de Paula AC; Kerstenestzy M; Pianovski MA; Costa MI; Santos FC; Martins AM; Aranda CS; Correa Neto J; Holanda GB; Cardoso L; da Silva CA; Bonatti RC; Ribeiro BF; Rodrigues Mdo C; Llerena JC
Mol Genet Metab; 2013 May; 109(1):62-9. PubMed ID: 23535281
[TBL] [Abstract][Full Text] [Related]
8. Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study.
Harmatz P; Giugliani R; Schwartz I; Guffon N; Teles EL; Miranda MC; Wraith JE; Beck M; Arash L; Scarpa M; Yu ZF; Wittes J; Berger KI; Newman MS; Lowe AM; Kakkis E; Swiedler SJ;
J Pediatr; 2006 Apr; 148(4):533-539. PubMed ID: 16647419
[TBL] [Abstract][Full Text] [Related]
9. Aryplase (Biomarin).
Yogalingam G
Curr Opin Investig Drugs; 2004 Oct; 5(10):1111-20. PubMed ID: 15535433
[TBL] [Abstract][Full Text] [Related]
10. Molecular markers for the follow-up of enzyme-replacement therapy in mucopolysaccharidosis type VI disease.
Di Natale P; Villani GR; Parini R; Scarpa M; Parenti G; Pontarelli G; Grosso M; Sersale G; Tomanin R; Sibilio M; Barone R; Fiumara A
Biotechnol Appl Biochem; 2008 Mar; 49(Pt 3):219-23. PubMed ID: 17672828
[TBL] [Abstract][Full Text] [Related]
11. Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapy.
Braunlin E; Rosenfeld H; Kampmann C; Johnson J; Beck M; Giugliani R; Guffon N; Ketteridge D; Sá Miranda CM; Scarpa M; Schwartz IV; Leão Teles E; Wraith JE; Barrios P; Dias da Silva E; Kurio G; Richardson M; Gildengorin G; Hopwood JJ; Imperiale M; Schatz A; Decker C; Harmatz P;
J Inherit Metab Dis; 2013 Mar; 36(2):385-94. PubMed ID: 22669363
[TBL] [Abstract][Full Text] [Related]
12. Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).
Harmatz P; Whitley CB; Waber L; Pais R; Steiner R; Plecko B; Kaplan P; Simon J; Butensky E; Hopwood JJ
J Pediatr; 2004 May; 144(5):574-80. PubMed ID: 15126989
[TBL] [Abstract][Full Text] [Related]
13. Management of infusion-related reactions to enzyme replacement therapy in a cohort of patients with mucopolysaccharidosis disorders.
Miebach E
Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S100-6. PubMed ID: 20040319
[TBL] [Abstract][Full Text] [Related]
14. Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI.
Brunelli MJ; Atallah ÁN; da Silva EM
Cochrane Database Syst Rev; 2016 Mar; 3():CD009806. PubMed ID: 26943923
[TBL] [Abstract][Full Text] [Related]
15. Galsulfase (Naglazyme®) therapy in infants with mucopolysaccharidosis VI.
Harmatz PR; Garcia P; Guffon N; Randolph LM; Shediac R; Braunlin E; Lachman RS; Decker C
J Inherit Metab Dis; 2014 Mar; 37(2):277-87. PubMed ID: 24108527
[TBL] [Abstract][Full Text] [Related]
16. The effect of galsulfase enzyme replacement therapy on the growth of patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).
Harmatz P; Hendriksz CJ; Lampe C; McGill JJ; Parini R; Leão-Teles E; Valayannopoulos V; Cole TJ; Matousek R; Graham S; Guffon N; Quartel A;
Mol Genet Metab; 2017 Sep; 122(1-2):107-112. PubMed ID: 28457718
[TBL] [Abstract][Full Text] [Related]
17. Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase.
Harmatz P; Ketteridge D; Giugliani R; Guffon N; Teles EL; Miranda MC; Yu ZF; Swiedler SJ; Hopwood JJ;
Pediatrics; 2005 Jun; 115(6):e681-9. PubMed ID: 15930196
[TBL] [Abstract][Full Text] [Related]
18. Repeated intrathecal injections of recombinant human 4-sulphatase remove dural storage in mature mucopolysaccharidosis VI cats primed with a short-course tolerisation regimen.
Auclair D; Finnie J; White J; Nielsen T; Fuller M; Kakkis E; Cheng A; O'Neill CA; Hopwood JJ
Mol Genet Metab; 2010 Feb; 99(2):132-41. PubMed ID: 19896877
[TBL] [Abstract][Full Text] [Related]
19. Immune response to enzyme replacement therapy: 4-sulfatase epitope reactivity of plasma antibodies from MPS VI cats.
Turner CT; Hopwood JJ; Bond CS; Brooks DA
Mol Genet Metab; 1999 Jul; 67(3):194-205. PubMed ID: 10381327
[TBL] [Abstract][Full Text] [Related]
20. Galsulfase.
Hopwood JJ; Bate G; Kirkpatrick P
Nat Rev Drug Discov; 2006 Feb; 5(2):101-2. PubMed ID: 16521329
[No Abstract] [Full Text] [Related]
[Next] [New Search]
